Stock Earnings

Question 1

¿Cuáles son los estados financieros clave de BioMarin Pharmaceutical Inc?

Accepted Answer

Según el último estado financiero (Form-10K), BioMarin Pharmaceutical Inc tiene un total de activos de $6,988, una ganancia neta profit de $426

Question 2

¿Cuáles son los ratios financieros clave para BMRN?

Accepted Answer

El ratio corriente de BioMarin Pharmaceutical Inc es 5.25, el margen neto es 14.93, las ventas por acción son $14.5.

Question 3

¿Cómo se desglosan los ingresos de BioMarin Pharmaceutical Inc por segmento o geografía?

Accepted Answer

BioMarin Pharmaceutical Inc largest revenue segment is NAGLAZYME, at a revenue of 479,584,000 in the most earnings release.For geography, Royalty and Other is the primary market for BioMarin Pharmaceutical Inc, at a revenue of 44,470,000.

Question 4

¿Es rentable BioMarin Pharmaceutical Inc?

Accepted Answer

yes, según los últimos estados financieros, BioMarin Pharmaceutical Inc tiene una ganancia neta profit de $426

Question 5

¿Tiene BioMarin Pharmaceutical Inc alguna deuda?

Accepted Answer

yes, BioMarin Pharmaceutical Inc tiene una deuda de 1,330

Question 6

¿Cuántas acciones en circulación tiene BioMarin Pharmaceutical Inc?

Accepted Answer

BioMarin Pharmaceutical Inc tiene un total de acciones en circulación de 190.76

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	3,094	2,853	2,419	2,096	1,846	1,860
Revenue Growth (YoY)	12%	18%	15%	14%	-1%	9%
Cost of Revenue	577	580	532	483	470	524
Gross Profit	2,516	2,273	1,887	1,612	1,375	1,336
Selling, General & Admin	963	913	892	831	760	737
Research & Development	903	747	746	649	628	628
Operating Expenses	1,890	1,703	1,701	1,547	1,459	1,432
Other Non Operating Income (Expenses)	1	-4	-38	-2	11	7
Pretax Income	679	541	188	149	-75	-42
Income Tax Expense	158	114	20	8	-7	-46
Net Income	520	426	167	141	-64	859
Net Income Growth	61%	155%	18%	-320%	-107%	-3,835%
Shares Outstanding (Diluted)	192.03	196.7	191.59	189	182.9	191.7
Shares Change (YoY)	-3%	3%	1%	3%	-5%	7%
EPS (Diluted)	2.71	2.17	0.87	0.75	-0.37	4.48
EPS Growth	66%	148%	17%	-303%	-108%	-3,546%
Free Cash Flow	825	475	51	44	185	-52
Free Cash Flow Per Share	4.29	2.41	0.26	0.23	1.01	-0.27
Gross Margin	81.31%	79.67%	78%	76.9%	74.48%	71.82%
Operating Margin	20.2%	19.97%	7.64%	3.05%	-4.49%	-5.16%
Profit Margin	16.8%	14.93%	6.9%	6.72%	-3.46%	46.18%
Free Cash Flow Margin	26.66%	16.64%	2.1%	2.09%	10.02%	-2.79%
EBITDA	707	666	289	166	25	9
EBITDA Margin	22.85%	23.34%	11.94%	7.91%	1.35%	0.48%
D&A For EBITDA	82	96	104	102	108	105
EBIT	625	570	185	64	-83	-96
EBIT Margin	20.2%	19.97%	7.64%	3.05%	-4.49%	-5.16%
Effective Tax Rate	23.26%	21.07%	10.63%	5.36%	9.33%	109.52%

BioMarin Pharmaceutical Inc (BMRN) Price

BMRN Stock Price Chart

BMRN Income

Follow-Up Questions